SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-18-009543
Filing Date
2018-02-16
Accepted
2018-02-16 16:05:33
Documents
11
Period of Report
2018-02-14
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tv486339_8k.htm 8-K 48186
2 EXHIBIT 4.1 tv486339_ex4-1.htm EX-4.1 707351
3 EXHIBIT 10.1 tv486339_ex10-1.htm EX-10.1 70461
4 EXHIBIT 99.1 tv486339_ex99-1.htm EX-99.1 18741
5 GRAPHIC tv486339_ex4-1img1.jpg GRAPHIC 2862
6 GRAPHIC tv486339_ex4-1img2.jpg GRAPHIC 3666
7 GRAPHIC tv486339_ex4-1img3.jpg GRAPHIC 3652
8 GRAPHIC tv486339_ex4-1img4.jpg GRAPHIC 3836
9 GRAPHIC tv486339_ex4-1img5.jpg GRAPHIC 3077
10 GRAPHIC tv486339_ex4-1img6.jpg GRAPHIC 5181
11 GRAPHIC tv486339_ex99-1img1.jpg GRAPHIC 12949
  Complete submission text file 0001144204-18-009543.txt   895706
Mailing Address 16640 CHESTERFIELD GROVE ROAD SUITE 200 CHESTERFIELD MO 63005
Business Address BLOCK 10-1 BLANCHARDSTOWN CORPORATE PARK BALLYCOOLIN DUBLIN L2 15 636-449-1830
AVADEL PHARMACEUTICALS PLC (Filer) CIK: 0001012477 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37977 | Film No.: 18621207
SIC: 2834 Pharmaceutical Preparations